Posted on June 18, 2009 by Patients and Patents
A landmark collaboration could see the development of the first new-action tuberculosis drug in 40 years. Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership, and Tibotec, a Johnson & Johnson company, have joined forces to focus on the development of the new experimental drug TMC207.
Forbes reports that if the drug [...]
Filed under: Innovation, Public health | Tagged: drug development, Innovation, tuberculosis, World Health Organization | Leave a Comment »
Posted on May 20, 2009 by Patients and Patents
WHO Director-General Dr Margaret Chan and United Nations Secretary-General Ban Ki-moon met with over 30 vaccine manufacturers from developing and developed countries at WHO headquarters yesterday. Industry representatives affirmed their wish to cooperate in making supplies of any eventual vaccine for Influenza A(H1N1) available to developing countries, and said they stood ready to produce the [...]
Filed under: Public health, World Health Organization | Tagged: drug development, H1N1, Innovation, vaccine, World Health Organization | 1 Comment »
Posted on January 19, 2009 by Patients and Patents
A new Pharmaceutical Price Regulation Scheme (PPRS) came into effect in the U.K. on January 1, 2009. The PPRS represents an attempt to balance incentives for innovation with cost and price restraint. The objectives of the 2009 PPRS are:
To deliver value for money; securing the provision of safe and effective medicines at reasonable prices;
To encourage innovation [...]
Filed under: Innovation, Public health | Tagged: drug development, drug pricing, Europe, Innovation | Leave a Comment »
Posted on November 3, 2008 by Patients and Patents
Not surprisingly, the recent crisis in global financial markets has been front page news for the past few weeks. The Wall Street Journal and other major publications have noted that the impact of this crisis goes well beyond the stock market.
The Convergence Law Institute posted a number of comments in their blog about the impact of the [...]
Filed under: intellectual property | Tagged: drug development, Innovation | Leave a Comment »
Innovative vaccine venture offers hope to less-developed countries
Britain’s largest charity, the Wellcome Trust, and pharmaceutical company Merck & Co. have joined together to create a non-profit, £90-million (about $150 million) research center in India to facilitate the development of new vaccines, “including [those for] neglected diseases for which inadequate or no vaccines exist.” According to Nature News, “the move marks the first [...]
Filed under: Commentary on news & events, Innovation | Tagged: access to medicines, drug development, least-developed countries, neglected diseases, vaccine | 2 Comments »